Portage Biotech Inc.
PRTG
$5.42
-$0.54-9.06%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 91.02% | 79.45% | 40.47% | 34.67% | 27.98% |
Total Depreciation and Amortization | -35.19% | -7.32% | 59.26% | 325.00% | 5,300.00% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -100.41% | -83.43% | -41.11% | -40.13% | -35.16% |
Change in Net Operating Assets | 54.58% | 885.59% | -62.67% | 1,454.17% | 9,920.00% |
Cash from Operations | 61.80% | 52.86% | 35.24% | 6.14% | -18.42% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | 557.98% | 557.98% |
Cash from Investing | -- | -- | -- | 555.75% | 555.75% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -17.50% | -60.71% | -147.06% | 97.91% | 98.00% |
Issuance of Common Stock | -64.27% | -86.89% | 45.72% | 49.11% | 101.88% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | 109.30% | 107.27% | 100.63% | 98.91% |
Cash from Financing | -64.75% | -87.16% | 49.99% | 994.89% | 5,200.85% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 39.13% | 53.32% | 85.50% | 67.62% | 56.92% |